There is no single answer to how long osteoporosis treatment lasts because the medications work differently, carry different risks with extended use, and are monitored and adjusted over time based on your individual response. What is true for all of them is that osteoporosis treatment is a long-term commitment, not a short course.

CALLOUT: Unlike antibiotics or short courses of medication, osteoporosis treatment is measured in years, not weeks. The bones you are protecting took years to weaken. Protecting them takes time too.

Bisphosphonates and the bisphosphonate holiday

Oral bisphosphonates (alendronate and risedronate) are typically taken for three to five years initially, after which your doctor will reassess. Zoledronic acid is usually given for three annual infusions before reassessment.

After several years of bisphosphonate use, many doctors recommend a planned treatment break, sometimes called a "bisphosphonate holiday." This is possible because bisphosphonates bind to bone and remain there for years after you stop taking them, providing ongoing protection even during the break. The holiday reduces the small cumulative risk of atypical femoral fractures associated with long-term use.

  • Women at moderate risk may take a break of one to two years after three to five years of treatment
  • Women at higher risk may continue for longer before a break, or may not take a holiday at all
  • During a holiday, bone density is monitored and treatment is restarted if significant loss occurs

QUOTE: "A bisphosphonate holiday is not stopping treatment. Rather, it is a managed pause, based on the understanding that the medication has already embedded itself in your bone and continues to work even in its absence."

Prolia - an ongoing commitment

Prolia does not offer the same flexibility as bisphosphonates. Because its protective effect wears off approximately six months after each injection, and because stopping abruptly carries a risk of rapid rebound bone loss, Prolia is generally considered an ongoing treatment rather than one with a defined endpoint.

Women on Prolia are typically monitored indefinitely with regular injections every six months, annual or biennial DEXA scans, and periodic reassessment of the overall treatment plan. If Prolia is eventually stopped, a transition to another medication is almost always necessary.

CALLOUT: If you are on Prolia and concerned about long-term use, raise it with your doctor but do not stop without a plan. The conversation about how long to continue is an important one, and your doctor can help you weigh the ongoing benefit against any concerns you have.

Anabolic medications - defined courses

Teriparatide (Forteo) and abaloparatide (Tymlos) are limited to a maximum of two years of use in a lifetime limit for each medication. Romosozumab (Evenity) is limited to twelve months. These are not arbitrary restrictions. They reflect both the clinical evidence and precautionary limits based on long-term safety data.

After completing a course of an anabolic medication, transitioning immediately to an antiresorptive medication is essential. The bone density gained during the anabolic phase can be lost rapidly if no follow-on treatment is given.

CALLOUT: Anabolic medications are a beginning, not an end. The work they do in building new bone is only preserved if it is followed by a maintenance medication. Your doctor will plan this transition before your course ends.

Reassessment - how treatment evolves over time

Osteoporosis treatment is not set and forgotten. But the reality for many women is that it can feel that way. Doctor reviews are infrequent, appointments are short, and years can pass without anyone asking whether the medication is still the right choice, whether it is working, or whether anything has changed.

If that sounds familiar, you are not alone. It is one of the most common frustrations women share after years on treatment.

Ideally, your doctor will reassess your treatment plan every one to two years based on:

  • Your DEXA scan results: is density stable, improving, or declining?
  • Your fracture risk: has it changed as you have aged or as your health has changed?
  • Side effects and tolerability: is the medication still appropriate for you?
  • New clinical evidence: have guidelines changed since you started treatment?

CALLOUT: If your medication has never been formally reviewed, or if years have passed since anyone discussed whether it is still right for you, it is worth raising at your next appointment. You can use Lenari's medication guide and the questions in Article “How to talk to your doctor: questions to bring to your next appointment” of the Just Diagnosed section to prepare for that conversation.

QUOTE: "The goal of treatment evolves over time. In the first years, it is about stopping the loss. Later, it may be about maintaining stability. The medication and the timeline should reflect where you are in that journey and someone should be checking."

What happens if you stop taking your medication

Stopping osteoporosis medication for any reason, without medical guidance generally results in bone density returning to its pre-treatment trajectory. For bisphosphonates, this happens gradually due to the medication's residual activity in bone. For Prolia, it can happen rapidly. For anabolic medications, it happens quickly if no follow-on treatment is given.

If you are struggling with your medication, speak to your doctor before stopping. There are usually alternatives, adjustments, or support options that have not yet been explored.